Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability

Jessica R. Bobbitt(Cleveland Clinic Lerner College of Medicine), Ruth A. Keri(Cleveland Clinic)
Journal of Biological Chemistry
January 16, 2025
Cited by 0


Related Papers